<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03578835</url>
  </required_header>
  <id_info>
    <org_study_id>DZIF TTU 08.810</org_study_id>
    <nct_id>NCT03578835</nct_id>
  </id_info>
  <brief_title>Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes</brief_title>
  <acronym>BLOOMY-COM</acronym>
  <official_title>Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Lübeck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Köln</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continual surveillance of both community-acquired and nosocomial bloodstream infections for
      specific target organisms. Analysis of comorbidities, complications, bacterial resistance
      patterns, bacterial genomics (e. g. via WGS and MLST typing) for the determinants of clinical
      outcomes. The clinical outcomes are investigated both in the short-term (up until discharge)
      and the long-term (six months after index blood culture by standardized questionnaire). A
      predictive point-of-care score is to be developed based on these data to define high-risk
      patient populations requiring more intensive diagnostic and/or treatment regimens.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>Short-term mortality due to bloodstream infection</measure>
    <time_frame>From index blood culture to discharge, an average of 16 days</time_frame>
    <description>Mortality due to bloodstream infection up to hospital discharge in association to causative species, resistance pattern, comorbidities, complications etc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term mortality due to bloodstream infection</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>Mortality due to bloodstream infection up to long-term follow-up after 6 months in association to causative species, resistance pattern, comorbidities, complications etc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term morbidity due to bloodstream infection</measure>
    <time_frame>At 6 months</time_frame>
    <description>Morbidity as measured by the SF-36 questionnaire due to bloodstream infection after 6 months in association to causative species, resistance pattern, comorbidities, complications etc.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Bloodstream Infection</condition>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>Multi-center BSI cohort</arm_group_label>
    <description>Patients from six German study centers suffering from bloodstream infection caused by specific target organisms.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bacterial strains isolated from blood cultures and samples derived thereof (such as purified
      DNA).
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult inpatients with at least one blood culture positive for any of the target organisms:
        Staphylococcus aureus, Enterococcus spp., Escherichia coli, Enterobacter spp., Klebsiella
        spp., Acinetobacter baumannii, Pseudomonas aeruginosa.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years old

          -  Informed consent given either by patient or guardian

          -  Inpatient

          -  At least one blood culture positive for one of the following bacteria: Staphylococcus
             aureus, Enterococcus spp., Escherichia coli, Enterobacter spp., Klebsiella spp.,
             Acinetobacter baumannii, Pseudomonas aeruginosa

        Exclusion Criteria:

          -  Less than 18 years old

          -  Not capable of giving informed consent nor informed consent given by guardian

          -  Outpatient

          -  No blood cultures positive for any of the target organisms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Evelina Tacconelli, Prof.</last_name>
    <phone>004970712983685</phone>
    <email>Evelina.Tacconelli@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Winfried Kern, Prof.</last_name>
    <phone>004976127018190</phone>
    <email>winfried.kern@uniklinik-freiburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Bade-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Württemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Justus-Liebig-Universität Gießen</name>
      <address>
        <city>Gießen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätskliniken Köln</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 4, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2018</study_first_posted>
  <last_update_submitted>July 4, 2018</last_update_submitted>
  <last_update_submitted_qc>July 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Evelina Tacconelli</investigator_full_name>
    <investigator_title>Prof. Infectious Diseases, FESCMID,ESCMID Education Officer,EUCIC Chair</investigator_title>
  </responsible_party>
  <keyword>BSI</keyword>
  <keyword>SF-36</keyword>
  <keyword>Clinical Outcome</keyword>
  <keyword>Whole Genome Sequencing</keyword>
  <keyword>Predictive Score</keyword>
  <keyword>Bloodstream Infection</keyword>
  <keyword>Septic Shock</keyword>
  <keyword>Multi-resistant Bacteria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

